文献速递生殖医学

促性腺激素释放激素拮抗剂方案与低获卵高风险年轻女性更高获卵数相关:一项使用三种统计方法的回顾性研究

Gonadotropin-releasing hormone antagonist protocol is associated with higher oocyte yield in young women at high risk for low oocyte retrieval: a retrospective study using three statistical methods.
PubMed 文献 · Fertil Steril · 2025-07-17

该回顾性队列研究纳入2023年1月至2025年4月间首次接受体外受精和卵胞浆内单精子注射治疗的≤35岁女性2068例,均经列线图预测为低获卵高风险(预测评分≥0.41)。比较促性腺激素释放激素拮抗剂方案与孕激素促排卵方案,经倾向性评分匹配后贝叶斯分析显示拮抗剂组获卵数更高、低获卵发生率更低,但最高风险亚组中孕激素促排卵方案显示潜在优势。

要点

  • 在低获卵高风险年轻女性中,拮抗剂方案获卵数高于孕激素促排卵方案(8.3 vs 5.3)。
  • 拮抗剂组低获卵(<10个卵母细胞)发生率低于孕激素促排卵方案(65.2% vs 86.0%)。
  • 风险分层分析显示低至中风险组拮抗剂方案降低低获卵发生率,最高风险亚组孕激素促排卵方案有潜在优势。

核心结论

  • 在低获卵高预测风险的年轻女性中,拮抗剂方案在最大化获卵方面优于孕激素促排卵方案。
  • 基于个体化风险刺激策略可能改善临床结局。

研究设计与样本

  • 回顾性队列研究,应用倾向性评分匹配前后的贝叶斯分析及基于风险的分层亚组分析。
  • 纳入2023年1月至2025年4月间首次接受体外受精和卵胞浆内单精子注射治疗的≤35岁女性2068例。
  • 低获卵高风险定义为经验证的列线图预测评分≥0.41。
  • 暴露因素为促性腺激素释放激素拮抗剂方案或孕激素促排卵方案,方案选择基于临床判断和患者特征。

主要发现

  • 倾向性评分匹配后,拮抗剂组平均获卵数高于孕激素促排卵方案组(8.3 vs 5.3;支持备择假设的贝叶斯因子BF10>10^28)。
  • 拮抗剂组获卵率高于孕激素促排卵方案组(88.2% vs 81.2%;BF10>10^3)。
  • 拮抗剂组低获卵(<10个卵母细胞)发生率低于孕激素促排卵方案组(65.2% vs 86.0%;BF10>10^19)。
  • 胚胎质量或受精率未见显著差异。
  • 风险分层分析显示,拮抗剂方案显著降低低至中风险组的低获卵发生率(中位比值比0.30-0.57,BF10最高达647.8),而最高风险亚组中孕激素促排卵方案显示潜在优势。

临床怎么用

  • 原文结论认为拮抗剂方案在低获卵高预测风险的年轻女性中优于孕激素促排卵方案,强调基于个体化风险刺激策略的价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study whether the gonadotropin-releasing hormone (GnRH) antagonist protocol is associated with improved oocyte retrieval outcomes compared with the progestin-primed ovarian stimulation (PPOS) protocol in young women at high predicted risk for low oocyte yield. DESIGN: Retrospective cohort study applying Bayesian analysis before and after propensity score matching, and risk-based stratified subgroup analysis. SUBJECTS: A total of 2,068 women aged ≤35 years undergoing their first in vitro fertilization and intracytoplasmic sperm injection treatment cycles between January 2023 and April 2025, identified as high risk for low oocyte retrieval (predicted score ≥0.41) using a validated nomogram incorporating factors such as age, antimüllerian hormone levels, antral follicle count, basal follicle-stimulating hormone levels, and follicle-stimulating hormone:luteinizing hormone ratio. EXPOSURE: Ovarian stimulation with either a GnRH antagonist protocol or a PPOS protocol, with protocol selection on the basis of clinical judgment and patient characteristics. MAIN OUTCOME MEASURES: Incidence of low oocyte retrieval (<10 oocytes) and the number of oocytes retrieved. RESULTS: Among 2,068 young women at high predicted risk for low oocyte yield, the GnRH antagonist protocol resulted in significantly better ovarian stimulation outcomes compared with the PPOS protocol. After propensity score matching, the antagonist group had a higher mean number of oocytes retrieved (8.3 vs. 5.3; Bayes factor in favor of the alternative hypothesis [BF10] >1028) and a higher oocyte retrieval rate (88.2% vs. 81.2%; BF10 >103). The incidence of low oocyte retrieval (<10 oocytes) was significantly lower in the antagonist group (65.2% vs. 86.0%; BF10 >1019). No significant differences were observed in embryo quality or fertilization rates. Risk-based stratified analysis showed that the GnRH antagonist protocol significantly reduced the incidence of low oocyte retrieval in low-risk to midrisk groups (median odds ratio, 0.30-0.57, BF10 up to 647.8), whereas in the highest-risk subgroup, PPOS showed a potential advantage. CONCLUSION: The GnRH antagonist protocol is superior to PPOS in maximizing oocyte retrieval among young women at high predicted risk for low oocyte retrieval, highlighting the value of individualized risk-based stimulation strategies to improve clinical outcomes.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Teng Y, Pan P, Yang H, et al. Gonadotropin-releasing hormone antagonist protocol is associated with higher oocyte yield in young women at high risk for low oocyte retrieval: a retrospective study using three statistical methods. Fertil Steril. 2025. PMID: 40683454. doi:10.1016/j.fertnstert.2025.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。